Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why DermTech Still Has Ten-Bagger Potential


Dermtech (NASDAQ: DMTK) is an upstart healthcare company that's revolutionizing the way skin care is detected -- with a simple patch rather than a biopsy.

In this segment of "The 5," recorded on Nov. 23, Fool contributors Connor Allen and Jason Hall discuss Dermtech and how that skin-cancer-detection innovation could lead to multi-bagging returns.

Continue reading


Source Fool.com

Like: 0
Share

Comments